Figure 3From: A distinct epigenetic signature at targets of a leukemia proteinAML1-target gene validation. A. Relative position of the AML1-consensus motifs (left) and their sequence (right) in the five putative AML1-target genes that were analyzed by ChIP. B. Quantitative ChIP analysis with antibodies either against AML1 or MTG16 showing a significant (p < 0.05) enrichment of chromatin containing AML1-consensus motifs vs. chromatin containing a control region in AML1-MTG16-negative and AML1-MTG16-positive cells, respectively.Back to article page